Flag International Outside United States
intl/data image

Urgent ® PC Clinical Data

There are numerous publications highlighting the use of percutaneous tibial nerve stimulation (PTNS) in the treatment of urinary urgency, urinary frequency, urge incontinence and faecal incontinence.

The Urgent PC Neuromodulation System is the only system available to provide PTNS treatment. The device technology and treatment protocol are founded on the SANS device (Stoller's Afferent Nerve Stimulator).

The following abstracts are listed by publication year with the most recent listed first.  

Click on the article title to view the full abstract:

Search clinical data abstracts:

Display clinical data pertaining to the treatment of:
 
Treatment interval frequency of percutaneous tibial nerve stimulation (PTNS): 18-month results from the STEP Study.
Peters, K., Carrico, D., Wooldridge, L. (2011) International Continence Society (ICS) Annual Meeting, Glasgow, UK
SUmiT Trial Outcomes: Clinical Insights Into Percutaneous Tibial Nerve Stimulation.
Sand, P., Peters, K., Carrico, D. (2011) International Continence Society (ICS) Annual Meeting, Glasgow, UK
12 month percutaneous tibial nerve stimulation treatment interval results: outcomes from the OrBIT Trial.
MacDiarmid, S., et al. (2010). Poster, International Continence Society, Toronto, Canada.
Comparative effectiveness: percutaneous tibial nerve stimulation (PTNS) and sacral nerve stimulation (SNS) for overactive bladder (OAB) treatment.
MacDiarmid, S.A. et al. (2010). Poster, Society for Urodynamics and Female Urology, St. Petersburg, FL.
Percutaneous tibial nerve stimulation for the treatment of overactive bladder: treatment interval frequency.
MacDiarmid, S.A., et al. (2010). Poster, Society for Urodynamics and Female Urology, St. Petersburg, FL.
New efficacy data on percutaneous tibial nerve stimulation: a multi-center, randomized, sham-controlled trial for overactive bladder syndrome.
Peters, K.M., et al. (2010). Presentation, Society for Urodynamics and Female Urology, St. Petersburg, FL.
6 and 12 month results from OrBIT trial comparing percutaneous tibial nerve stimulation (PTNS) vs. extended-release tolterodine.
Peters, K., et al. (2009). Poster, International Continence Society, San Francisco, CA.
Percutaneous tibial nerve stimulation: Efficacy with patients also taking anticholinergics.
Wooldridge, L. (2009). Poster, International Continence Society, San Francisco, CA.
Percutaneous tibial nerve stimulation (PTNS): A literature-based assessment.
MacDiarmid, S.A., et al. (2009). Current Bladder Dysfunction Reports, 4, 29-33.
Long term sustained therapeutic effect of percutaneous tibial nerve stimulation in the management of Overactive Bladder.
MacDiarmid, S.A., et al. (2009). Presentation, American Urological Association Annual Meeting, Chicago, IL.
A randomized multicenter study comparing percutaneous tibial nerve stimulation with pharmaceutical therapy for the treatment of overactive bladder.
Peters, K.M., et al. (2008). Presentation, Late Breaking Science Forum, American Urological Association Annual Meeting, Orlando, FL.
Percutaneous tibial nerve stimulation: The Urgent PC device.
van Balkan, M.R. (2007). Expert Rev Med Devices, 4(5), 693-698.
Percutaneous tibial nerve stimulation (PTNS): Results at long-term follow-up.
Cappellano, F., et al. (2006). Poster, SIUD National Congress, Italy.
Posterior tibial nerve stimulation (PTNS) in the treatment of LUTS secondary to Parkinson's Disease.
Finazzi-Agrò, E., et al. (2006). Poster, SUID National Congress, Italy.
Prognostic factors for successful percutaneous tibial nerve stimulation.
van Balken, M.R., et al. (2006). Eur Urol, 49(2), 360-365.
Posterior tibial nerve stimulation in the treatment of urge incontinence.
Vandoninck, V., et al. (2003). Neuro Urodyn, 22, 17-23.
Temporary sacral and tibial neuromodulation in treating patients with overactive urinary bladder.
Mazo, E.B., & Krivoborodov, G.G. (2002). Zurnal Voprosy Nejrochirurgii Imeni NN Burdenko, 1, 17-21.
The efficacy of Stoller Afferent Nerve Stimulation in frequency/urgency syndrome: A randomised control trial.
Vohra, A.K., et al. (2002). Abstract 217, ICS 32nd Annual Meeting, Heidelberg.
Afferent nerve stimulation for pelvic floor dysfunction.
Stoller, M.L. (1999). Eur Urol, 35 (suppl 2), 16.

MORE CLINICAL DATA

Urgent PC
Urgent® PC

Macroplastique
Macroplastique

 

 

PTQ Implants

 

 

Vox implants